Particle Therapy Market by Therapy Type, Component, Configuration, Cancer Type, End-User - Global Forecast 2025-2030- Product Image

Sale

Particle Therapy Market by Therapy Type, Component, Configuration, Cancer Type, End-User - Global Forecast 2025-2030

Report
185 Pages
October 2024
Region: Global
360iResearch™
ID: 5674447

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Particle Therapy Market grew from USD 772.41 million in 2023 to USD 831.50 million in 2024. It is expected to continue growing at a CAGR of 7.94%, reaching USD 1.31 billion by 2030.

Particle therapy, a form of external beam radiotherapy, utilizes protons, neutrons, or positive ions for cancer treatment, offering superior precision over traditional radiotherapy by delivering high-energy particles that directly target tumors with minimal damage to surrounding tissue. Its necessity is underscored by the rising incidence of cancers requiring precision treatment, particularly in sensitive areas like the head, neck, and spine. Applications span across oncological treatment, with expanding interest in pediatric cases due to reduced long-term side effects. End-use predominantly includes specialized cancer treatment centers and advanced healthcare research facilities. Market growth is propelled by technological advancements, increasing cancer rates, and government healthcare expenditure; however, high setup costs, limited accessibility, and a steep learning curve for professionals present significant challenges. Recent market opportunities align with technological innovations such as enhanced imaging and treatment precision, with emerging economies offering untapped potential due to healthcare infrastructure development. The market is also poised for growth through strategic collaborations and investments, alongside integrating artificial intelligence to personalize treatment. Key recommendations for stakeholders include investing in research and development to improve cost-effectiveness, enhancing training programs for medical staff, and exploring public-private partnerships to lower barriers to accessibility. Limitations arise from infrastructural constraints, high cost of equipment, and stringent regulatory compliance. Furthermore, the pandemic-induced supply chain disruptions may also affect material availability. Innovative areas for exploration include machine learning algorithms for treatment planning, hybrid therapy systems combining various particle types, and exploring potential applications beyond oncology, such as in ophthalmology and neurology. The nature of the market is highly competitive yet fragile, dependent on technological prowess and regulatory milestones, with heightened focus needed on sustainable expansion in underserved regions.

Understanding Market Dynamics in the Particle Therapy Market

The Particle Therapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Need for advanced therapies in cancer treatment
- Rise in adoption of particle therapy in clinical trials
- Growing number of particle therapy centers worldwide
Market Restraints
- High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
Market Opportunities
- Ongoing proton therapy research programs
- Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
Market Challenges
- Risk associated with the particle therapy radiation exposure

Exploring Porter’s Five Forces for the Particle Therapy Market

Porter’s Five Forces framework further strengthens the insights of the Particle Therapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Particle Therapy Market

External macro-environmental factors deeply influence the performance of the Particle Therapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Particle Therapy Market

The Particle Therapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Particle Therapy Market

The Particle Therapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Particle Therapy Market

The Particle Therapy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapy Type
- Heavy Ion Therapy
- Proton Therapy
Component
- Product
  - Cyclotrons
  - Synchrocyclotrons
  - Synchrotrons
- Service
Configuration
- Multi-room System
- Single-room System
Cancer Type
- Breast Cancer
- Head & Neck Cancer
- Lung Cancer
- Pediatric Cancer
- Prostate Cancer
End-User
- Ambulatory Surgery Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advanced therapies in cancer treatment
5.1.1.2. Rise in adoption of particle therapy in clinical trials
5.1.1.3. Growing number of particle therapy centers worldwide
5.1.2. Restraints
5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
5.1.3. Opportunities
5.1.3.1. Ongoing proton therapy research programs
5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
5.1.4. Challenges
5.1.4.1. Risk associated with the particle therapy radiation exposure
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Particle Therapy Market, by Therapy Type

6.1. Introduction
6.2. Heavy Ion Therapy
6.3. Proton Therapy

7. Particle Therapy Market, by Component

7.1. Introduction
7.2. Product
7.2.1. Cyclotrons
7.2.2. Synchrocyclotrons
7.2.3. Synchrotrons
7.3. Service

8. Particle Therapy Market, by Configuration

8.1. Introduction
8.2. Multi-room System
8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

9.1. Introduction
9.2. Breast Cancer
9.3. Head & Neck Cancer
9.4. Lung Cancer
9.5. Pediatric Cancer
9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Particle Therapy Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
14.3.2. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
14.3.3. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PARTICLE THERAPY MARKET DYNAMICS
TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 81. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 85. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 161. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 191. ITALY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ITALY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 209. NORWAY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NORWAY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 214. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. POLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. POLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. QATAR PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. QATAR PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. SPAIN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SPAIN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 263. TURKEY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. TURKEY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Particle Therapy market, which are profiled in this report, include:

Advanced Oncotherapy plc
B dot Medical Inc.
Best Particle Therapy, Inc.
BioSig Technologies Inc.
Covenant Health
Danfysik A/S
Elekta AB
Hitachi, Ltd.
IBA International
Koninklijke Philips N.V.
Mevion Medical Systems
Mitsubishi Electric Corporation
New Mexico Cancer Center
Optivus Proton Therapy, Inc.
P-Cure Ltd
ProTom International
Provision Healthcare, LLC
PTW Freiburg GmbH
SAH Global LLC
Shanghai APACTRON Particle Equipment Co., Ltd.
Siemens Healthineers GmbH
Stantec Inc.
Sumitomo Heavy Industries, Ltd.
Toshiba Medical Systems Corporation
Xstrahl Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 831.5 Million
Forecasted Market Value ( USD ) by 2030	$ 1310 Million
Compound Annual Growth Rate	7.9%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Particle Therapy Market

Exploring Porter’s Five Forces for the Particle Therapy Market

Applying PESTLE Analysis to the Particle Therapy Market

Analyzing Market Share in the Particle Therapy Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Particle Therapy Market

Strategic Recommendations for Success in the Particle Therapy Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Particle Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Proton Therapy, Heavy Ion Therapy), System, Application (Treatment, Research), Cancer Type (Pediatric, Breast, Lung), Region, and Segment Forecasts, 2024-2030

Particle Therapy Global Market Report 2024

Particle Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

Particle Therapy - Global Strategic Business Report